TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 677,353 | 517,067 | 388,418 |
Financial expenses | 9,784 | 5,017 | 4,881 |
Earnings before taxes | 133,417 | 143,498 | 102,810 |
Total assets | 402,851 | 388,149 | 269,551 |
Current assets | 357,695 | 340,361 | 215,352 |
Current liabilities | 246,085 | 228,590 | 141,820 |
Equity capital | 156,766 | 156,624 | 125,209 |
- share capital | 7,187 | 6,971 | 6,489 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 38.9% | 40.4% | 46.5% |
Turnover per employee | 17,655 | ||
Profit as a percentage of turnover | 19.7% | 27.8% | 26.5% |
Return on assets (ROA) | 35.5% | 38.3% | 40.0% |
Current ratio | 145.4% | 148.9% | 151.8% |
Return on equity (ROE) | 85.1% | 91.6% | 82.1% |
Change turnover | 144,265 | 99,821 | -34,501 |
Change turnover % | 27% | 24% | -8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.